Genomics

Dataset Information

0

H3K9me3 ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib

ABSTRACT: H3K9me3 ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib

PROVIDER: PRJNA660051 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR12542153.fastq.gz Fastqsanger.gz
SRR12542154.fastq.gz Fastqsanger.gz
SRR12542155.fastq.gz Fastqsanger.gz
SRR12542156.fastq.gz Fastqsanger.gz
SRR12542157.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 8

Similar Datasets

Genomics H3K9me3 ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib
2020-08-31 | GSE157097 | GEO
Genomics H3K27ac ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib, fulvestrant
2020-09-01 | GSE157222 | GEO
Genomics ATAC-seq analysis of human breast cancer cell lines treated with abemaciclib
2020-08-31 | GSE157082 | GEO
Transcriptomics RNA-seq analysis of human breast cancer cell lines treated with abemaciclib
2020-09-03 | GSE157383 | GEO
Genomics Enhancer connectome analysis of human breast cancer cell lines treated with abemaciclib
2020-09-03 | GSE157381 | GEO
Genomics H3K27ac ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib, fulvestrant
| PRJNA660462 | ENA
Genomics ATAC-seq analysis of human breast cancer cell lines treated with abemaciclib
| PRJNA660031 | ENA
Genomics RNA-seq analysis of human breast cancer cell lines treated with abemaciclib
| PRJNA661088 | ENA
Genomics Enhancer connectome analysis of human breast cancer cell lines treated with abemaciclib
| PRJNA661087 | ENA
Transcriptomics Efficacy of abemaciclib in palbociclib-resistant hormone receptor positive breast cancer cell lines: MCF-7 and T47D
2023-07-10 | GSE222367 | GEO